See the Glossary for more terms.
NIAID welcomes our new Council members for 2014: Anita S. Chong, Larry S. Schlesinger, Arlene Sharpe, and Chris Wilson.
Adaora Adimora, M.D., M.P.H., is professor of medicine and epidemiology at the University of North Carolina at Chapel Hill. She is a physician-epidemiologist with specialty training and extensive clinical experience in infectious diseases with a focus on HIV. Her research has characterized the epidemiology of heterosexual HIV transmission among African Americans, highlighted the role of sexual network patterns in the spread of HIV, and underscored the importance of macroeconomic and social forces in racial disparities in the U.S. HIV epidemic. Dr. Adimora serves as chair of the NIH HIV Prevention Trials Network Women at Risk Committee and is a member of the HHS Panel on Antiretroviral Guidelines for Adults and Adolescents. (October 31, 2015)
Dázon Dixon Diallo, M.P.H., is president and CEO of SisterLove, Inc. and adjunct faculty in public health at Morehouse School of Medicine. She is a founding board member of SisterSong Women of Color Reproductive Justice Collective. Ms. Diallo chairs the Fulton County HIV/AIDS Services Planning Council (Ryan White Council) and the steering committee of the Global Campaign for Microbicides. She is also a founding member and co-chair of the Community Advisory Board of Emory University’s HOPE Clinic. Ms. Diallo developed a seminal behavioral prevention intervention, part of the CDC’s National Compendium of Evidenced-Based HIV Prevention Interventions. (October 31, 2014)
Georgia D. Tomaras, Ph.D., is associate professor of surgery, immunology, and molecular genetics and microbiology at Duke University Medical Center as well as a faculty member of its Center for Virology and the Computational Biology and Bioinformatics Program. She is also associate director of research and director of the Training and Mentoring Program at the Duke Human Vaccine Institute. The goal of her research program is to understand the cellular and humoral immune responses to HIV-1 infection and vaccination that are involved in protection from HIV-1. Her laboratory focuses on the induction and ontogeny of systemic and mucosal antibody responses and antiviral CD8+ T cell responses. (October 31, 2015)
Jerome A. Zack, Ph.D., is professor, Department of Medicine and Department of Microbiology, Immunology, and Molecular Genetics at the David Geffen School of Medicine at the University of California, Los Angeles. He is also the director of the UCLA Center for AIDS Research (CFAR). Dr. Zack is best known for his innovative work on how the AIDS virus replicates and causes disease and developing new therapeutic approaches for eradicating the AIDS virus. His work has also shown that the AIDS virus can inhibit the function of hematopoietic stem cells, and he is studying the potential of human embryonic stem cells for hematopoietic gene therapy. (October 31, 2014)
Michael J. Holtzman, M.D., is the Seldin Professor of Medicine, professor of cell biology, and director of pulmonary and critical care medicine at Washington University School of Medicine. His research group studies infectious and inflammatory lung disease and uses a variety of scientific approaches to define pathogenesis and discover new drugs to address this problem. Dr. Holtzman’s research group also focuses on the connection between respiratory viral infection and the development of chronic obstructive lung diseases, such as asthma and COPD. He has served as editor in chief and editorial board member for scientific journals and as an NIH study section member. (October 31, 2014)
Norma Sue Kenyon, Ph.D., is Martin Kleiman Professor of Surgery, Microbiology and Immunology, and Biomedical Engineering at the Leonard M. Miller School of Medicine at the University of Miami. She is also executive director of the Wallace H. Coulter Center for Translational Research and senior associate dean for Translational Science. She and her team are focused on biological replacement therapies for patients with type 1 diabetes, including novel approaches for enhancement of islet engraftment and long-term function, cotransplantation of bone marrow derived stem cells with insulin producing cells, and identification of biomarkers for rejection and recurrent autoimmunity. (October 31, 2014)
Arlene Sharpe, M.D., Ph.D., is George Fabyan Professor of Comparative Pathology at Harvard Medical School. She is also head of the Division of Immunology in the Department of Microbiology and Immunobiology and co-director of the Harvard Institute of Translational lmmunology. Dr. Sharpe is a leader in the field of costimulation. Her laboratory currently focuses on the roles of T cell costimulatory pathways in regulating pathogenic and protective immune responses needed for inducing and maintaining T cell tolerance and effective antimicrobial and antitumor immunity. Her laboratory is also involved in studies aimed at translating fundamental understanding of T cell costimulation into new therapies for autoimmune diseases, chronic viral infections, and tumor immunotherapy. (October 31, 2017)
Mavis Agbandje-McKenna, Ph.D., is professor in the Department of Biochemistry and Molecular Biology and director of the Center for Structural Biology in the College of Medicine at the University of Florida. Her laboratory uses structural biology and biophysical tools combined with biochemistry and molecular biology to study single-stranded DNA viruses. The goal of her research is to obtain a fundamental understanding of the virus and host determinants of tissue tropism, host adaptation, host pathogenicity, and virus-host immune system interactions. (October 31, 2015)
Norman W. Baylor, Ph.D., is president and CEO of Biologics Consulting Group, Inc. Previously, Dr. Baylor was the director of the Office of Vaccines Research and Review in the Food and Drug Administration’s Center for Biologics Evaluation and Research. He evaluated and facilitated the development and licensure of numerous vaccines. Dr. Baylor served as FDA’s liaison to CDC’s Advisory Committee on Immunization Practices, U.S. Department of Health and Human Services National Vaccine Advisory Committee, and the Advisory Commission on Childhood Vaccines. He also served as an expert advisor to the World Health Organization on several global vaccine initiatives. (October 31, 2016)
Larry S. Schlesinger, M.D., is Samuel Saslaw Professor and chair of the Department of Microbial Infection and Immunity in the College of Medicine at The Ohio State University. He also serves as director of the OSU Center for Microbial Interface Biology and Medical Scientist Training Program. Dr. Schlesinger is a cellular immunologist whose studies focus on the pathogenesis of tuberculosis and other airborne infections caused by intracellular pathogens that subvert lung immune mechanisms. He has been a member or chair of several study sections at NIH and other federal and private agencies. (October 31, 2017)
For more information, see the Advisory Council portal.
Last Updated August 20, 2014
Last Reviewed January 06, 2014